Pubblicazioni scientifiche

2024

1. Angyal D, Kleinfelder K, Ciciriello F, Groeneweg TA, De Marchi G, de Pretis N, Bernardoni L, Rodella L, Tomba F, De Angelis P, Surace C, Pintani E, Alghisi F, de Jonge HR, Melotti P, Sorio C, Lucidi V, Bijvelds MJC, Frulloni L.
   CFTR function is impaired in a subset of patients with pancreatitis carrying rare CFTR variants.
   Pancreatology 2024 May;24(3):394-403. doi: 10.1016/j.pan.2024.03.005. Epub 2024 Mar 10. PMID: 38493004.
2. Campagna G, Amato A, Majo F, Ferrari G, Quattrucci S, Padoan R, Floridia G, Salvatore D, Carnovale V, Puppo Fornaro G, Taruscio D, Salvatore M; Gruppo di lavoro RIFC. Registro Italiano Fibrosi Cistica (RIFC).
   Rapporto 2021-2022 [Italian Cystic Fibrosis Registry (ICFR). Report 2021-2022].
   Epidemiol Prev. 2024 Mar-Apr;48(2 Suppl 2):1-41. Italian. doi: 10.19191/EP24.2.S2.031. Erratum in: Epidemiol Prev. 2024 May-Jun;48(3):192. doi: 10.19191/EP24.3.ERRATA.053. PMID: 38742380.
3. Ciciriello F, Panariello F, Medino P, Biffi A, Alghisi F, Rosazza C, Annunziata P, Bouchè V, Grimaldi A, Guidone D, Venturini A, Alicandro G, Oggioni M, Cerino P, Paiola G, Gramegna A, Fiocchi A, Bandera A, Lucidi V, Cacchiarelli D, Galietta LJV, Colombo C.
   Covid-19 in cystic fibrosis patients compared to the general population: Severity and virus-host cell interactions.
   J Cyst Fibros. 2024 Jul;23(4):625-632. doi: 10.1016/ j.jcf.2024.03.006. Epub 2024 Mar 19. PMID: 38508950.
4. Cipolli M, Boni C, Penzo M, Villa I, Bolamperti S, Baldisseri E, Frattini A, Porta G, Api M, Selicato N, Roccia P, Pollutri D, Marinelli Busilacchi E, Poloni A, Caporelli N, D’Amico G, Pegoraro A, Cesaro S, Oyarbide U, Vella A, Lippi G, Corey SJ, Valli R, Polini A, Bezzerri V.
   Ataluren improves myelopoiesis and neutrophil chemotaxis by restoring ribosome biogenesis and reducing p53 levels in Shwachman-Diamond syndrome cells.
   Br J Haematol. 2024 Jan;204(1):292-305. doi: 10.1111/ bjh.19134. Epub 2023 Oct 24. PMID: 37876306; PMCID: PMC10843527.
5. Di Gioia S, Lucca F, Venditto L, Sandri G, Tommasi N, Cipolli M, Molteni G.
   Efficacy of Elexacaftor-Tezacaftor-Ivacaftor on chronic rhinosinusitis in cystic fibrosis.
   Am J Otolaryngol. 2024 May-Jun; 45(3):104236. doi: 10.1016/j.amjoto. 2024.104236. Epub 2024 Feb 24. PMID: 38417261.
6. Fainardi V, Cresta F, Sorio C, Melotti P, Pesce E, Deolmi M, Longo F, Kleinfelder K, Esposito S, Pisi G.
   Elexacaftor/ tezacaftor/ivacaftor in people with cystic fibrosis and rare mutations.
   Pediatr Pulmonol. 2024 Aug 30. doi: 10.1002/ppul.27211. Epub ahead of print. PMID: 39212240.
7. Gambazza S, Mariani A, Guarise R, Ferrari B, Carta F, Brivio A, Bizzarri S, Castellani C, Colombo C, Laquintana D.
   Short-term effects of positive expiratory pressure mask on ventilation inhomogeneity in children with cystic fibrosis: A randomized, sham-controlled crossover study.
   Pediatr Pulmonol. 2024 May;59(5):1354-1363. doi: 10.1002/ ppul.26915. Epub 2024 Feb 16. PMID: 38362833.
8. Gramegna A, Alicandro G, Premuda C, Lucca F, Pinali L, Retucci M, Vespro V, Andrisani MC, Carraffiello G, Amati F, Volpi S, Aliberti S, Cipolli M, Blasi F.
   Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease.
   2024 Sep;166(3):433-441. doi: 10.1016/j.chest. 2024.03.033. Epub 2024 Mar 21. PMID: 38521181.
9. Kleinfelder K, Melotti P, Hristodor AM, Fevola C, Taccetti G, Terlizzi V, Sorio C.
   CFTR modulators response of S737F and T465N CFTR variants on patient-derived rectal organoids.
   Orphanet J Rare Dis. 2024 Sep 13;19(1):343. doi: 10.1186/ s13023-024-03334-3. PMID: 39272186; PMCID: PMC11401437.
10. Latorre RV, Calicchia M, Bigliardi M, Conti J, Kleinfelder K, Melotti P, Sorio C.
    Functional rescue of CFTR in rectal organoids from patients carrying R334W variant by CFTR modulators and PDE4 inhibitor Roflumilast.
    Respir Investig. 2024 May;62(3):455-461. doi: 10.1016/ j.resinv.2024.03.003. Epub 2024 Mar 27. PMID: 38547757.
11. Melotti P, Angyal D, Bijvelds MJC, Frulloni L.
    Reply to: Cystic fibrosis transmembrane conductance regulator (CFTR) variants and CFTR function in patients with pancreatitis.
    2024 Sep;24(6):971-972. doi: 10.1016/j.pan.2024.07.015. Epub 2024 Jul 30. PMID: 39095297.
12. Montresor A, D’Ulivo B, Preato S, Farinazzo A, Pintani E, Chiara ED, Torroni L, Verlato G, Boscia S, Pisano L, Mangone G, Ricci S, Azzari C, Taccetti G, Terlizzi V, Cipolli M, Melotti P, Sorio C, Laudanna C.
    Real-Life Experience with CFTR Modulators Shows Correction of LAD-IV Phenotype in Cystic Fibrosis.
    Am J Respir Cell Mol Biol. 2024 Oct;71(4):495-498. doi: 10.1165/rcmb.2024-0136LE. PMID: 39352210.
13. Pegoraro A, Bezzerri V, Tridello G, Brignole C, Lucca F, Pintani E, Danesino C, Cesaro S, Fioredda F, Cipolli M.
    Growth Charts for Shwachman-Diamond Syndrome at Ages 0 to 18 Years.
    Cancers (Basel). 2024 Apr 5;16(7):1420. doi: 10.3390/cancers16071420. PMID: 38611098; PMCID: PMC11010856.
14. Piona C, Mozzillo E, Tosco A, Zusi C, Emiliani F, Volpi S, Di Candia F, Raia V, Boselli ML, Trombetta M, Cipolli M, Bonadonna RC, Maffeis C.
    A longitudinal study of glucose tolerance in cystic fibrosis: the central role of beta cell functional mass.
    J Clin Endocrinol Metab. 2024 Jul 12:dgae474. doi: 10.1210/ clinem/dgae474. Epub ahead of print. PMID: 38994570.
15. Sellers ZM, Assis DN, Paranjape SM, Sathe M, Bodewes F, Bowen M, Cipolli M, Debray D, Green N, Hughan KS, Hunt WR, Leey J, Ling SC, Morelli G, Peckham D, Pettit RS, Philbrick A, Stoll J, Vavrina K, Allen S, Goodwin T, Hempstead SE, Narkewicz MR.
    Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations.
    2024 May 1;79(5):1220-1238. doi: 10.1097/ HEP.0000000000000646. Epub 2023 Oct 26.PMID: 37934656; PMCID: PMC11020118.
16. Semenchuk J, Naito Y, Charman SC, Carr SB, Cheng SY, Marshall BC, Faro A, Elbert A, Gutierrez HH, Goss CH, Karadag B, Burgel PR, Colombo C, Salvatore M, Padoan R, Daneau G, Harutyunyan S, Kashirskaya N, Kirwan L, Middleton PG, Ruseckaite R, de Monestrol I, Naehrlich L, Mondejar-Lopez P, Jung A, van Rens J, Bakkeheim E, Orenti A, Zomer-van Ommen D, da Silva-Filho LVR, Fernandes FF, Zampoli M, Stephenson AL; Global CF Registry Collaboration.
    Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study.
    J Cyst Fibros. 2024 Sep;23(5):815-822. doi: 10.1016/j.jcf.2024.07.019. Epub 2024 Aug 26. PMID: 39191560.
17. Spanoudakis M, Yilmaz Karapinar D, Dale D, Bolyard AA, Tran E, Roganovic J, Bartels M, Kapor S, Guardo D, Yacobovich J, Nilsson C, Bezzerri V, Cipolli M, Pegoraro A, Aleksov E, Guenova M, Dufour C, Fioredda F, Papadaki HA, Palmblad J.
    COVID-19 disease in patients with chronic neutropenia: The experience from the European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias.
    Br J Haematol. 2024 Jun;204(6):2480-2483. doi: 10.1111/bjh.19411. Epub 2024 Mar. PMID: 38506338.
18. Terlizzi V, Fevola C, Castaldo A, Del Vespa S, Dolce D, Scarallo L, Kleinfelder K, Melotti P, Sorio C, Taccetti G, Lionetti P.
    Non pathological sweat test, pancreatic insufficiency and Cystic Fibrosis: an unusual case in a child with F508del-duplication of exons 1–3 CFTR genotype.
    BMC Pediatrics, Nov 20; 24(1):752. doi: 10.1186/s12887-024-05154-7.
19. Wilschanski M, Munck A, Carrion E, Cipolli M, Collins S, Colombo C, Declercq D, Hatziagorou E, Hulst J, Kalnins D, Katsagoni CN, Mainz JG, Ribes-Koninckx C, Smith C, Smith T, Van Biervliet S, Chourdakis M.
    ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis.
    Clin Nutr. 2024 Feb;43(2):413-445. doi: 10.1016/j.clnu.2023.12.017. Epub 2023 Dec 27. PMID: 38169175.